Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,160,945
+$269,442 QoQ
Shares Held
8,729
+6.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.90%
of 13F equity value
Holder Rank
#1,047
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity Asset Management, Inc. holds $13,024,966 across 11 Drug Manufacturers - General names. AMGN ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
This page
|
8,729 | $3,160,945 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
31,404 | $1,809,498 | |
| 3 | JNJ |
Johnson & Johnson
|
5,968 | $1,515,692 | |
| 4 | GSK |
GSK plc
|
25,025 | $1,311,810 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,134 | $1,280,329 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,942 | $1,149,047 | |
| 7 | LLY |
ELI LILLY & Co
|
569 | $682,475 | |
| 8 | ABBV |
AbbVie Inc.
|
2,707 | $681,189 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,160,945 | 8,729 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,891,503 | 8,218 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,675,759 | 8,175 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,689,366 | 9,530 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,021,629 | 3,659 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $2,377,126 | 7,630 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $993,038 | 3,810 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,262,558 | 7,022 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,417,112 | 7,736 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,103,730 | 3,882 | Shares | Sole | 2024-05-28 | |
| 2023-12-31 | $1,145,743 | 3,978 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,028,007 | 3,825 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $780,622 | 3,516 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $753,534 | 3,117 | Shares | Sole | 2023-05-24 | |
| 2022-12-31 | $784,768 | 2,988 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $557,639 | 2,474 | Shares | Sole | 2022-11-16 | |
| 2022-03-31 | $763,667 | 3,158 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $770,072 | 3,423 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $763,838 | 3,592 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $844,350 | 3,464 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $813,359 | 3,269 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $752,298 | 3,272 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $732,489 | 2,882 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $735,883 | 3,120 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $678,942 | 3,349 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||